Levodopa Plus Occlusion Therapy versus Occlusion Therapy Alone for Children with Anisometropic Amblyopia
- PMID: 31875101
- PMCID: PMC6825694
- DOI: 10.18502/jovr.v14i4.5451
Levodopa Plus Occlusion Therapy versus Occlusion Therapy Alone for Children with Anisometropic Amblyopia
Abstract
Purpose: This study aimed to compare the effects of short-term administration of levodopa plus occlusion therapy versus occlusion therapy alone in preschool children with hyperopic anisometropic amblyopia.
Methods: This comparative interventional study included 40 eligible preschool children aged 6 to 7 years with hyperopic anisometropic amblyopia. The primary outcome measure was the logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity recorded at baseline, 3 weeks after the treatment initiation and 12 weeks after the treatment termination. The results were compared between the two groups.
Results: No statistically significant intergroup difference was observed in baseline logMAR visual acuities (P = 0.92). The mean logMAR visual acuities of the amblyopic eyes were significantly better in both groups three weeks after the treatment initiation than the baseline (P 0.01 in both groups). At 12 weeks after treatment termination, the logMAR visual acuities of the amblyopic eyes were significantly better than the baseline values (P 0.001 in the placebo group and P = 0.09 in the levodopa group). Intergroup comparisons revealed no statistically significant difference in visual acuities 3 weeks after the treatment initiation (P = 0.11) and 12 weeks after the treatment termination (P=0.10). Twelve weeks after the treatment termination, visual acuities regressed 0.037 logMAR in the placebo group and 0.042 logMAR in the levodopa group. These regression rates were not significantly different (P = 0.89).
Conclusion: The results of this study provide evidence that adding short-term administration of levodopa to occlusion therapy in hyperopic anisometropic amblyopia offers no additional benefit in visual outcomes and provides no advantage in terms of the regression rate.
Keywords: Anisometropic; Levodopa; Amblyopia; Occlusion Therapy.
Copyright © 2019 Farvardin et al.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Long-term changes in visual acuity and refractive error in amblyopes.Optom Vis Sci. 2004 Jul;81(7):510-5. doi: 10.1097/00006324-200407000-00012. Optom Vis Sci. 2004. PMID: 15252350
-
A morphological study of amblyopic eyes in children failing to achieve normal visual acuity after electronically monitored long-term occlusion treatment.Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):2021-8. doi: 10.1007/s00417-015-3085-0. Epub 2015 Jun 23. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 26100453
-
Levodopa-carbidopa with occlusion in older children with amblyopia.J AAPOS. 2002 Dec;6(6):368-72. doi: 10.1067/mpa.2002.129043. J AAPOS. 2002. PMID: 12506278 Clinical Trial.
-
Visual Acuity Improvement in Continuous vs Divided Occlusion in Anisometropic Amblyopia.Open Ophthalmol J. 2018 Feb 14;12:1-6. doi: 10.2174/1874364101812010001. eCollection 2018. Open Ophthalmol J. 2018. PMID: 29515681 Free PMC article. Review.
-
Systematic Evaluation of Levodopa Effect on Visual Improvement in Amblyopia: A Meta-analysis.Clin Neuropharmacol. 2020 Jan/Feb;43(1):20-25. doi: 10.1097/WNF.0000000000000372. Clin Neuropharmacol. 2020. PMID: 31738189
Cited by
-
Efficacy of Amblyopia Treatments in Children Up to Seven Years Old: A Systematic Review.Cureus. 2024 Mar 22;16(3):e56705. doi: 10.7759/cureus.56705. eCollection 2024 Mar. Cureus. 2024. PMID: 38650802 Free PMC article. Review.
-
Analysis of the improvement in monocular amblyopia visual acuity caused by the changes in non-amblyopia visual acuity in 74 adults.Medicine (Baltimore). 2023 Sep 15;102(37):e34606. doi: 10.1097/MD.0000000000034606. Medicine (Baltimore). 2023. PMID: 37713888 Free PMC article.
-
Macular pigment optical density of hyperopic anisometropic amblyopic patients measured by fundus reflectometry.Front Med (Lausanne). 2022 Oct 11;9:991423. doi: 10.3389/fmed.2022.991423. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36304187 Free PMC article.
-
Levodopa/Carbidopa to Augment the Treatment of Amblyopia: A Report by the American Academy of Ophthalmology.Ophthalmology. 2023 Nov;130(11):1221-1227. doi: 10.1016/j.ophtha.2023.07.008. Epub 2023 Aug 29. Ophthalmology. 2023. PMID: 37642618 Free PMC article.
-
Human equivalent doses of L-DOPA rescues retinal morphology and visual function in a murine model of albinism.Sci Rep. 2023 Oct 11;13(1):17173. doi: 10.1038/s41598-023-44373-3. Sci Rep. 2023. PMID: 37821525 Free PMC article.
References
-
- von Noorden GK. Binocular vision and ocular motility: theory and practice of management of strabismus. 5th ed. Lous Mosby-Year Book; 1996:216–254,512–520.
-
- Keech RV. y of Ophthalmology. San Francisco, CA: American Academy; 2000. Practical management of amblyopia. in. Focal points: clinical modules for ophthalmologist; p. 18.
-
- Arruga A. Effect of occlusion of amblyopic eye on amblyopia and eccentric fixation. Trans Oph Soc UK. 45–49: 82; 1962.
-
- Leguire LE., Rogers GL., Bremer DL., Walson P., Hadjieonstantinou-Neff M. Hadjieonstantinou-Neff M. Levodopa and childhood amblyopia. J Pediatr Ophthalmol Strabismus. 0–8: 29; 1992. Levodopa and childhood amblyopia. J Pediatr Ophthalmol Strabismus; pp. 29–290. - PubMed
-
- Leguire L. E., Rogers G. L., Bremer D. L., Walson P. D., McGregor M. L. Levodopa/carbidopa for childhood amblyopia. Investigative Ophthalmology & Visual Science. 1993;34(11):3090–3095. - PubMed
Publication types
LinkOut - more resources
Full Text Sources